Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Goodman

Showing results (621-630 of 1,119) with videos related to

Pageof 112
Sort By:
Kidney International|July 1, 1987
"High-dose" calcitriol for control of renal osteodystrophy in children on CAPDI B Salusky, R N Fine, H Kangarloo, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|August 18, 2001
Heparin reacts with and inactivates nitric oxideG R Upchurch, D G Goodman, S R Willoughby, et al.
Experimental Neurology|February 21, 2008
The metabolic profile of early Huntington's disease--a combined human and transgenic mouse studyAnna O G Goodman, Peter R Murgatroyd, Gema Medina-Gomez, et al.
Circulation|April 1, 2020
Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUSJohn H Alexander, Daniel Wojdyla, Amit N Vora, et al.
The American Journal of Cardiology|November 10, 2010
Relation between hemoglobin level and recurrent myocardial ischemia in acute coronary syndromes detected by continuous electrocardiographic monitoringMelissa Rousseau, Raymond T Yan, Mary Tan, et al.
European Heart Journal|November 17, 2019
Real-world risk of cardiovascular outcomes associated with hypertriglyceridaemia among individuals with atherosclerotic cardiovascular disease and potential eligibility for emerging therapiesPatrick R Lawler, Gynter Kotrri, Maria Koh, et al.
BMJ (Clinical Research Ed.)|July 5, 2003
Prospective observational cohort study of time saved by prehospital thrombolysis for ST elevation myocardial infarction delivered by paramedicsDavid K Pedley, Kim Bissett, Elizabeth M Connolly, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 22, 2017
Adjunctive use of anticoagulants at the time of percutaneous coronary intervention in patients with an acute coronary syndrome treated with fondaparinux: a multinational retrospective reviewJill E Abell, Shiona M Laing, Tara C Barker, et al.
American Journal of Industrial Medicine|November 14, 1997
The CARET asbestos-exposed cohort: baseline characteristics and comparison to other asbestos-exposed cohortsS Barnhart, J Keogh, M R Cullen, et al.
Chest|July 24, 2008
Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Robert A Harrington, Richard C Becker, Christopher P Cannon, et al.
Pageof 112

Showing results (621-630 of 1,119) with videos related to

Sort By:
Pageof 112
Kidney International|July 1, 1987
"High-dose" calcitriol for control of renal osteodystrophy in children on CAPDI B Salusky, R N Fine, H Kangarloo, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|August 18, 2001
Heparin reacts with and inactivates nitric oxideG R Upchurch, D G Goodman, S R Willoughby, et al.
Experimental Neurology|February 21, 2008
The metabolic profile of early Huntington's disease--a combined human and transgenic mouse studyAnna O G Goodman, Peter R Murgatroyd, Gema Medina-Gomez, et al.
Circulation|April 1, 2020
Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUSJohn H Alexander, Daniel Wojdyla, Amit N Vora, et al.
The American Journal of Cardiology|November 10, 2010
Relation between hemoglobin level and recurrent myocardial ischemia in acute coronary syndromes detected by continuous electrocardiographic monitoringMelissa Rousseau, Raymond T Yan, Mary Tan, et al.
European Heart Journal|November 17, 2019
Real-world risk of cardiovascular outcomes associated with hypertriglyceridaemia among individuals with atherosclerotic cardiovascular disease and potential eligibility for emerging therapiesPatrick R Lawler, Gynter Kotrri, Maria Koh, et al.
BMJ (Clinical Research Ed.)|July 5, 2003
Prospective observational cohort study of time saved by prehospital thrombolysis for ST elevation myocardial infarction delivered by paramedicsDavid K Pedley, Kim Bissett, Elizabeth M Connolly, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 22, 2017
Adjunctive use of anticoagulants at the time of percutaneous coronary intervention in patients with an acute coronary syndrome treated with fondaparinux: a multinational retrospective reviewJill E Abell, Shiona M Laing, Tara C Barker, et al.
American Journal of Industrial Medicine|November 14, 1997
The CARET asbestos-exposed cohort: baseline characteristics and comparison to other asbestos-exposed cohortsS Barnhart, J Keogh, M R Cullen, et al.
Chest|July 24, 2008
Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Robert A Harrington, Richard C Becker, Christopher P Cannon, et al.
Pageof 112